Moderna's mRNA-1083 vaccine shows promise in combining flu and COVID-19 protection, with positive Phase 3 results, potentially offering a more convenient approach for individuals.
The mRNA technology used in the combined vaccine signifies a significant advancement beyond COVID-19 and flu, hinting at future applications including cancer treatment and fighting multiple virus strains.
[
Collection
]
[
|
...
]